Lavo AI

About Lavo AI

Lavo Life Sciences provides an innovative, AI-powered platform called Crystal Console that enables pharmaceutical companies to predict and analyze crystal structures of small molecule drugs efficiently.

By importing, visualizing, and analyzing crystal data, users can identify potential risks like polymorphs that may impact drug stability and manufacturability.

The platform's virtual polymorph screening and PXRD analysis tools help discover novel polymorphs with improved properties, potentially opening new avenues for drug efficacy and patentability.

The technology significantly reduces turnaround times for crystal form identification, allowing teams to make faster, more informed decisions, mitigate development risks, and accelerate the overall drug pipeline.

With comprehensive insights into crystal behavior at the atomic level, Lavo Life Sciences empowers researchers to optimize solid-state formulations, avoid late-stage surprises, and improve drug stability.

The platform is designed for chemists, engineers, and R&D teams seeking to streamline their crystal structure analysis, reduce costs, and enhance their drug development success rate.

Backed by a team of experts in AI and computational chemistry, Lavo Life Sciences bridges the gap between cutting-edge technology and practical pharmaceutical application, transforming how drugs are developed from early discovery to market readiness..

Smart Features

• AI-powered crystal structure prediction accelerates drug development timelines
• Comprehensive analysis and visualization tools for crystal structures
• Virtual polymorph screening to identify potential polymorphs and reduce risks
• PXRD data analysis for accurate comparison with predicted structures
• Optimizes solid-state formulations for stability and manufacturability
• Reduces late-stage surprises and development costs
• Enables informed decision-making with advanced insights into crystal behavior
• Streamlines crystal form identification, saving time and resources

Use Cases & Applications

• Predicting and analyzing crystal structures of small molecule drugs
• Identifying potential polymorphs to mitigate development risks
• Optimizing drug formulations for stability and manufacturability
• Accelerating crystal form screening processes
• Discovering novel polymorphs with improved properties
• Reducing drug development time and costs
• Enhancing decision-making in early drug discovery and development

Who is it for?

• Pharmaceutical R&D teams and researchers
• Chemists and materials scientists involved in drug formulation
• Computational chemists and AI specialists in pharma
• Drug development project managers
• Regulatory affairs teams seeking detailed crystal data

Business Opportunities in Lavo AI

Leverage Lavo's AI-powered crystal structure prediction platform to offer specialized consulting and analytical services to pharmaceutical companies.

By developing expertise in crystal form analysis and polymorph screening, you can provide valuable insights that help clients reduce development risks, accelerate timelines, and improve drug formulations.

This creates a lucrative side business in pharmaceutical research support, especially as demand for efficient drug development solutions continues to grow..